The use of pegylated interferon is also indicated for the treatment of chronic HBV infection with proper patient selection when the therapeutic goal is finite therapy leading to immunological control of infection (virologic response, as defined as normal ALT with HBV DNA < 2000 IU/mL). This evidence concerns the gene GPT and infection.